[Postoperative vomiting].

Author: KarolinyVeronika, MurányiMiklós, NagyKatalin, PallósJúlia, SteiberJános, SzabóZsolt, VimlátiLászló

Paper Details 
Original Abstract of the Article :
INTRODUCTION: Nausea and vomiting following general anaesthesia are among the most frequent adverse reactions causing complications, the relief of which is an absolute demand. 5-HT3 receptor antagonists, such as ondansetron, belonging to the latest class of antiemetics were launched more than a deca...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/12053882

データ提供:米国国立医学図書館(NLM)

Preventing Postoperative Vomiting: A New Approach

The field of anesthesiology constantly seeks ways to minimize the discomfort and complications associated with surgery. This study delved into the use of ondansetron, a medication that blocks a specific type of receptor involved in nausea and vomiting, to prevent postoperative nausea and vomiting (PONV).

The study design involved a double-blind, placebo-controlled trial with three groups of patients undergoing laparoscopic cholecystectomy. This method allowed the researchers to compare the effectiveness of ondansetron given before or after surgery to a control group receiving a placebo. The results showed that ondansetron significantly reduced the occurrence of PONV compared to the placebo group, particularly when given before surgery. This suggests that timing of administration can influence the effectiveness of the medication.

The authors also found that ondansetron was safe and well-tolerated by the patients, with no significant adverse events reported. This is important because it demonstrates the potential of ondansetron to provide relief from PONV without introducing additional risks.

A Safer and More Effective Way to Prevent Postoperative Nausea and Vomiting

These findings have significant implications for improving the postoperative experience for patients. The use of ondansetron, especially when administered before surgery, has the potential to drastically reduce the frequency and severity of PONV, leading to a more comfortable and speedy recovery.

Less Nausea, Less Worry, Better Recovery

This research shows that preventing PONV can have a significant impact on patient well-being. Just like a camel navigating a sandstorm, patients can better navigate the challenges of surgery with the help of ondansetron, leading to a smoother and more pleasant recovery.

Dr.Camel's Conclusion

This research is like discovering a hidden oasis that provides a much-needed reprieve from the discomfort of PONV. Ondansetron, especially when used preoperatively, seems to be a great tool for helping patients avoid the unpleasant side effects of surgery and recover more comfortably.

Date :
  1. Date Completed 2002-06-28
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

12053882

DOI: Digital Object Identifier

12053882

Related Literature

SNS
PICO Info
in preparation
Languages

Hungarian

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.